Fulcrum Therapeutics, Inc.FULCNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P0
Near historical low
vs 5Y Ago
-0.3x
Contraction
Streak
5 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.35% |
| 2024 | -12.53% |
| 2023 | -0.06% |
| 2022 | 36.63% |
| 2021 | 42.65% |
| 2020 | 62.74% |
| 2019 | 58.11% |
| 2018 | 84.80% |
| 2017 | 0.00% |